AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 21 min read$A

Dolsten Mikael sold $217K of A

Dolsten Mikael sold 1,600 shares of AGILENT TECHNOLOGIES, INC. (A) at $135.42 ($0.22M total) on 2026-05-29.

Original reporting
SEC EDGAR · Dolsten Mikael
Published Jun 2, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$A
Neutral
medium confidence
Mentioned
$A
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity, but this filing alone does not change the company’s fundamentals.

02

Market read

A director’s open-market sale is disclosed; absent other catalysts, expected impact is modest.

03

What to watch

No 10b5-1 plan is cited, but the sale size ($216.7K) is small relative to typical large-cap float, reducing interpretive power.

Relevance 6/10Novelty 6/10Timing: today’s SEC Form 4 disclosure (filed 2026-06-02)

Background

The article is an SEC EDGAR Form 4 insider transaction: a director reports an open-market sale of Agilent shares.

Company-level read

Ticker impact

$ANeutralMedium confidence
Context

Agilent director Dolsten Mikael sold 1,600 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited near-term impact; treat as low-signal unless part of a broader selling pattern.

Evidence & confidence

This is a routine Form 4 sale with no 10b5-1 plan and no accompanying fundamental news, so market reaction is typically muted.

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide read-across.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

A single director sale can reflect diversification or liquidity needs rather than bearish fundamentals.

Key entities

  • issuer
    Agilent Technologies, Inc.

    Subject of the SEC Form 4 insider sale disclosure.

  • director
    Dolsten Mikael

    Director who sold 1,600 shares at $135.42 on 2026-05-29.

Read at source← All news

Related articles

JUL 23
$AMed

Agilent Technologies Inc.: Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Agilent Technologies (NYSE: A) said the EU approved its PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic for epithelial ovarian, fallopian tube, or primary peritoneal carcinoma to identify patients whose tumors express PD-L1 and may be eligible for Merck’s KEYTRUDA (pembrolizumab). Agilent said it is the eighth CE-marked indication for this test.

finanznachrichten.de3 min
MAY 29
$ARMMedAI 9/10

Stocks Rebound Amid News of a US-Iran Deal

US Q1 GDP was revised to +1.6% (q/q annualized) from +2.0% expected; Q1 personal consumption was cut to +1.4%, while core PCE rose to a 3-year high of +4.4%. Apr new home sales fell 6.2% m/m to 622k. Stocks rebounded after Axios reported a preliminary US-Iran deal to extend the ceasefire 60 days and begin nuclear talks. Fed hawkishness weighed; markets priced a 3% chance of a 25 bp June cut.

finance.yahoo.com7 min
MAY 29
$INFQMedAI 9/10

11 Stocks Racking Up Monstrous Gains

On Thursday, 11 stocks with market caps above $2B and at least 5M shares traded posted double-digit gains, helping all three US indices finish higher (Nasdaq +0.91%, S&P 500 +0.58%, Dow +0.05%). Infleqtion rose 14.94% on plans to triple UK capacity; Best Buy gained 15.80% after Q1 fiscal 2027 results and guidance; Clover Health jumped 16.43% after a court order tied to 2026 star ratings; Agilent rose on Q2 earnings and raised outlook; Dollar Tree climbed 17.87% on Q1 revenue and sales growth.

insidermonkey.com6 min
MAY 28
$AMedAI 9/10

Benzinga

BofA Securities said Agilent Technologies’ fiscal Q2 results beat expectations, citing high single-digit growth in the Instruments segment driven by share gains, new platforms and replacement activity, and noting management raised full-year guidance by the size of the beat. RBC reported revenue of $1.83B (~6.3% organic growth) above estimates and also cited guidance increases. Shares rose 16.9% to $135.38.

benzinga.com2 min
MAY 28
$IBMMedAI 9/10

Stocks making the biggest moves midday: Unusual Machines, Snowflake, Arm, Dollar Tree & more

Midday movers: IBM rose ~3% after filing it will invest over $10B in quantum computing over five years. Arm jumped >15% as Mizuho raised its target to $360. Norfolk Southern and Union Pacific fell ~4% after the Surface Transportation Board halted review of their $71.5B merger. Snowflake surged 37% on Q2 margin/product revenue guidance; Dollar Tree rose 18% after raising FY earnings outlook.

cnbc.com8 min
MAY 28
$SNOWMedAI 9/10

S&P 500 Hits Record Highs, Snowflake Jumps 37% On AI Boom - Agilent Technologies (NYSE:A), Advanced Micro

U.S. stocks rose to record highs after reports of a 60-day ceasefire extension between Washington and Tehran and phased resumption of Strait of Hormuz tanker traffic. The S&P 500 gained 0.5% to 7,557.85. April PCE was mixed (headline 3.8% YoY; core 3.3%). Snowflake jumped 37% on AI-cloud demand; Agilent rose 17% on fiscal Q2 revenue $1.83B and non-GAAP EPS $1.49, with raised guidance.

benzinga.com5 min